Cronos Group Inc. Files Q3 2024 10-Q Report
Ticker: CRON · Form: 10-Q · Filed: 2024-11-12T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, cannabis
TL;DR
Cronos Group Q3 2024 10-Q filed. Financials and operations detailed.
AI Summary
Cronos Group Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quarter of 2024. Specific financial figures and business segment performance are outlined within the report.
Why It Matters
This filing provides investors with the latest financial health and operational performance of Cronos Group Inc., crucial for understanding its market position and future prospects in the cannabis industry.
Risk Assessment
Risk Level: medium — The cannabis industry is subject to significant regulatory, market, and operational risks, which are inherent in this type of filing.
Key Players & Entities
- Cronos Group Inc. (company) — Filer of the 10-Q report
- 20240930 (date) — Period of report for the 10-Q
- 20241112 (date) — Filing date of the 10-Q
- PharmaCan Capital Corp. (company) — Former company name of Cronos Group Inc.
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20240930, indicating the filing covers the period ending September 30, 2024.
When was this 10-Q filed with the SEC?
The filing date is 20241112.
What was Cronos Group Inc. formerly known as?
Cronos Group Inc. was formerly known as PharmaCan Capital Corp., with a name change date of 20151021.
What is the Standard Industrial Classification (SIC) code for Cronos Group Inc.?
The SIC code is 2833, MEDICINAL CHEMICALS & BOTANICAL PRODUCTS.
What is the fiscal year end for Cronos Group Inc.?
The fiscal year end is 1231.
From the Filing
0001656472-24-000102.txt : 20241112 0001656472-24-000102.hdr.sgml : 20241112 20241112073318 ACCESSION NUMBER: 0001656472-24-000102 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 97 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241112 DATE AS OF CHANGE: 20241112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cronos Group Inc. CENTRAL INDEX KEY: 0001656472 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38403 FILM NUMBER: 241443331 BUSINESS ADDRESS: STREET 1: 4491 CONCESSION RD 12 CITY: STAYNER STATE: A6 ZIP: L0M 1S0 BUSINESS PHONE: (416) 504-0004 MAIL ADDRESS: STREET 1: 6D - 7398 YONGE ST STREET 2: PMB 732 CITY: THORNHILL STATE: A6 ZIP: L4J 8J2 FORMER COMPANY: FORMER CONFORMED NAME: PharmaCan Capital Corp. DATE OF NAME CHANGE: 20151021 10-Q 1 cron-20240930.htm 10-Q cron-20240930 false 2024 Q3 0001656472 --12-31 00-0000000 P3Y P3Y P3Y xbrli:shares iso4217:USD iso4217:USD xbrli:shares cron:segment xbrli:pure iso4217:CAD iso4217:ILS iso4217:CAD xbrli:shares cron:shareholder cron:complaint cron:defendant 0001656472 2024-01-01 2024-09-30 0001656472 2024-11-07 0001656472 2024-09-30 0001656472 2023-12-31 0001656472 2024-07-01 2024-09-30 0001656472 2023-07-01 2023-09-30 0001656472 2023-01-01 2023-09-30 0001656472 us-gaap:CommonStockMember 2023-12-31 0001656472 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001656472 us-gaap:RetainedEarningsMember 2023-12-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001656472 us-gaap:NoncontrollingInterestMember 2023-12-31 0001656472 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001656472 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001656472 2024-01-01 2024-03-31 0001656472 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001656472 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001656472 us-gaap:CommonStockMember 2024-03-31 0001656472 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001656472 us-gaap:RetainedEarningsMember 2024-03-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001656472 us-gaap:NoncontrollingInterestMember 2024-03-31 0001656472 2024-03-31 0001656472 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001656472 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001656472 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001656472 2024-04-01 2024-06-30 0001656472 us-gaap:NoncontrollingInterestMember 2024-04-01 2024-06-30 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001656472 us-gaap:CommonStockMember 2024-06-30 0001656472 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001656472 us-gaap:RetainedEarningsMember 2024-06-30 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001656472 us-gaap:NoncontrollingInterestMember 2024-06-30 0001656472 2024-06-30 0001656472 us-gaap:NoncontrollingInterestMember 2024-07-01 2024-09-30 0001656472 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001656472 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001656472 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0001656472 us-gaap:CommonStockMember 2024-09-30 0001656472 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001656472 us-gaap:RetainedEarningsMember 2024-09-30 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001656472 us-gaap:NoncontrollingInterestMember 2024-09-30 0001656472 us-gaap:CommonStockMember 2022-12-31 0001656472 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001656472 us-gaap:RetainedEarningsMember 2022-12-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 00016